D
Duncan Cook
Researcher at Office for National Statistics
Publications - 7
Citations - 527
Duncan Cook is an academic researcher from Office for National Statistics. The author has contributed to research in topics: Population & Vaccination. The author has an hindex of 2, co-authored 7 publications receiving 93 citations.
Papers
More filters
Journal ArticleDOI
Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK.
Koen B. Pouwels,Koen B. Pouwels,Emma Pritchard,Emma Pritchard,Philippa C Matthews,Philippa C Matthews,Philippa C Matthews,Nicole Stoesser,David W Eyre,Karina Doris Vihta,Karina Doris Vihta,Thomas House,Thomas House,Jodie Hay,John I. Bell,John N Newton,Jeremy Farrar,Derrick W. Crook,Duncan Cook,Emma Rourke,Ruth Studley,Tim E. A. Peto,Ian Diamond,A. Sarah Walker +23 more
TL;DR: The effectiveness of BNT162b2 and ChAdOx1 vaccines against new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections requires continuous reevaluation, given the increasingly dominant B.1.617.2 (Delta) variant.
Posted ContentDOI
Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
Koen B. Pouwels,Koen B. Pouwels,Emma Pritchard,Emma Pritchard,Philippa C Matthews,Philippa C Matthews,Philippa C Matthews,Nicole Stoesser,DW Eyre,Vihta K-D.,Vihta K-D.,Thomas House,Thomas House,Jodie Hay,John I. Bell,John N Newton,Jeremy Farrar,D Crook,Duncan Cook,Emma Rourke,Ruth Studley,T Peto,Ian Diamond,Anne-Sophie Walker +23 more
TL;DR: The effectiveness of BNT162b2, ChAdOx1, and mRNA-1273 vaccines against new SARS-CoV-2 infections requires continuous re-evaluation, given the increasingly dominant Delta variant as mentioned in this paper.
Posted ContentDOI
Symptoms and SARS-CoV-2 positivity in the general population in the UK
Karina-Doris Vihta,Karina-Doris Vihta,Koen B. Pouwels,Koen B. Pouwels,Tim E. A. Peto,Emma Pritchard,Emma Pritchard,David W Eyre,Thomas House,Thomas House,Owen Gethings,Ruth Studley,Emma Rourke,Duncan Cook,Ian Diamond,Derrick W. Crook,Philippa C Matthews,Philippa C Matthews,Nicole Stoesser,Ann Sarah Walker,Ann Sarah Walker,Ann Sarah Walker +21 more
TL;DR: In this article, the authors compared symptoms in new PCR-positives and comparator test-negative controls and found that the differences are modest and do not currently warrant large-scale changes to targeted testing approaches.
Journal ArticleDOI
Symptoms and SARS-CoV-2 positivity in the general population in the UK.
Karina-Doris Vihta,Karina-Doris Vihta,Koen B. Pouwels,Koen B. Pouwels,Tim E. A. Peto,Emma Pritchard,Emma Pritchard,David W Eyre,Thomas House,Thomas House,Owen Gethings,Ruth Studley,Emma Rourke,Duncan Cook,Ian Diamond,Derrick W. Crook,Philippa C Matthews,Philippa C Matthews,Nicole Stoesser,Ann Sarah Walker,Ann Sarah Walker,Ann Sarah Walker +21 more
TL;DR: In this paper, the authors compared symptoms in PCR-positives vs. PCR-negatives, evaluating sensitivity of combinations of 12 symptoms and tests per case (TPC) for SARS-CoV-2 PCR-testing.
Posted ContentDOI
SARS-CoV-2 anti-spike IgG antibody responses after second dose of ChAdOx1 or BNT162b2 in the UK general population
Jia Wei,Koen B. Pouwels,Nicole Stoesser,Philippa C Matthews,Philippa C Matthews,Ian Diamond,Ruth Studley,Emma Rourke,Duncan Cook,John I. Bell,John N Newton,Jeremy Farrar,Alison Howarth,Alison Howarth,Brian D. Marsden,Sarah Hoosdally,E. Yvonne Jones,David I. Stuart,Derrick W. Crook,Tim E. A. Peto,A. Sarah Walker,David W Eyre +21 more
TL;DR: In this paper, the authors investigated anti-spike IgG antibody responses and correlates of protection following second doses of ChAdOx1 or BNT162b2 SARS-CoV-2 vaccines in the UK general population.